Announced Thu, 19 Mar · 17:46 IST

Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 ,inter alia, to consider and approve the second & ....

Fund Raising View source PDF

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹450.75
prior close
₹454.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.4+0.5-1.2-3.5-1.9+0.9-2.2-5.3+5.3+8.3+8.4+27.7+30.6
Up moveDown movePending
AI summary

Solara Active Pharma Sciences has informed the stock exchanges that its Rights Issue Committee will meet on March 24, 2026. The committee will consider making the Second and Final Call on partly paid-up equity shares that were issued to shareholders via a rights issue based on the Letter of Offer dated May 9, 2024. The board will also fix a Record Date to identify which shareholders are liable to pay this remaining call money. This means shareholders who applied for the 2024 rights issue still owe a portion of the share price, and the company is now moving to collect the final instalment.

Likely market impact

Eligible shareholders will need to pay the remaining call money by the deadline set after the record date. Failure to pay could result in forfeiture of the partly paid-up shares. The actual cash inflow to the company and impact on share price will depend on the call price and how many shareholders pay on time.